v3.25.2
Stock-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2025
Stock Settled Stock Appreciation Rights SARS [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our SSSARs compensation expense and tax benefits recorded for each of the years ended June 30:
202520242023
Compensation expense$— $1,038 $1,972 
Tax benefits$— $90 $216 
Intrinsic value of exercises$(18)$677 $3,873 
Fair Value Of Awards Vested
The total fair values of SSSARs vested for each of the years ended June 30 were as follows:
202520242023
Fair value of vested rights$— $1,175 $2,611 
Stock-Settled Stock Appreciation Rights Activity
The following table summarizes the activity relating to SSSARs granted under the plan for the year ended June 30, 2025:
Number of
Rights		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life in
Years		Aggregate
Intrinsic
Value
Outstanding at beginning of year39 $169.75 
Exercised(20)$163.69 
Granted— $— 
Forfeited— $— 
Outstanding at end of year19 $175.76 2.56$31 
Exercisable and vested at end of year19 $175.76 2.56$31 
Vested and expected to vest at end of year19 $175.76 2.56$31 
Stock-Settled Stock Appreciation Rights Outstanding By Grant Year
The following table summarizes information about the SSSARs outstanding by grant year at June 30, 2025:
 OutstandingExercisable
   Weighted Average  
Grant YearsRange of
Exercise Prices		Number
Outstanding		Remaining
Contractual
Life in
Years		Exercise
Price		Number
Exercisable		Weighted
Average
Exercise
Price
2021
$167.18-$177.99
182.62$177.4018$177.40
2020
$153.71
11.66$153.711$153.71
Employee Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2025, 2024 and 2023, we granted shares of restricted stock to various employees under the terms of the plan. The following table summarizes information relating to these grants:
202520242023
Employees
Restricted stock granted38 33 29 
Grant date fair value$7,292 $6,076 $4,448 
Weighted average grant date fair value per award$190.84 $185.05 $154.80 
Director Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2025, 2024 and 2023, we also granted shares of restricted stock to our nonemployee directors under the terms of the plan. The following table summarizes information relating to each of these grants:
202520242023
Nonemployee directors
Restricted stock granted6 5 4 
Grant date fair value$1,215 $920 $919 
Weighted average grant date fair value per award$200.28 $165.41 $203.34 
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our restricted stock compensation expense and tax benefits recorded for each of the years ended June 30:
202520242023
Compensation expense$5,673 $5,479 $4,432 
Tax benefits$859 $841 $677 
Fair Value Of Awards Vested
The total fair values of restricted stock vested for each of the years ended June 30 were as follows:
202520242023
Fair value of vested shares$5,125 $3,287 $4,996 
Restricted Stock Activity
The following table summarizes the activity relating to restricted stock granted under the plan for the year ended June 30, 2025:
Number of
Shares		Weighted
Average Grant
Date Fair Value
Unvested restricted stock at beginning of year80 $176.21 
Granted44 $192.14 
Vested(28)$183.25 
Forfeited(6)$184.23 
Unvested restricted stock at end of year90 $181.33 
Performance Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our performance units compensation expense and tax benefits recorded for each of the years ended June 30:
202520242023
Compensation expense$3,306 $4,842 $2,678 
Tax benefits$321 $620 $355 
Fair Value Of Awards Vested
The following table summarizes information for our performance units that vested during the year ended June 30:
2025
Payout of revenue-based performance units174 %
Payout of market-based performance units91 %
Fair value of vested performance units$3,281 
Stock-Based Compensation Grant Details
In 2025, 2024 and 2023, we granted performance units to various employees under the terms of the plan. The following table summarizes information relating to these grants:
202520242023
Performance units granted25 25 26 
Grant date fair value$5,248 $4,745 $4,572 
Weighted average grant date fair value per award$206.54 $192.91 $173.73 
Performance Units Grant Date Valuation Assumptions For our performance units with a market condition, the grant-date fair value is estimated using a Monte Carlo simulation. The assumptions used in the Monte Carlo simulation were as follows:
202520242023
Risk-free interest rate3.72 %4.60 %3.18 %
Dividend yield1.98 %1.78 %2.08 %
Volatility factor of the expected market price of our common stock26.40 %24.60 %32.20 %
Performance Units Activity
The following table summarizes the activity relating to performance units granted under the plan for the year ended June 30, 2025:
Number of
Units		Weighted
Average Grant
Date Fair Value
Unvested performance units at beginning of year62 $188.34 
Granted25 $206.54 
Vested(16)$201.70 
Forfeited(6)$192.75 
Unvested performance units at end of year65 $191.72